PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

BaseKit Secures $6.5M for Global Expansion

This latest round of funding follows the successful commercial launch of BaseKit less than ten months ago. The platform is being used by a wide range of businesses and individuals to create and manage their web presence.

BaseKit Secures $6.5M for Global Expansion
2011-04-18
LONDON, ENGLAND, April 18, 2011 (Press-News.org) BaseKit has raised $6.5m in venture capital from Nauta Capital, Eden Ventures and the National Endowment for Science, Technology and the Arts (NESTA) from a second round of funding that takes investment in the British-based company to a combined $10m in the past year. The funding will enable the company to rapidly expand its global reach with new offices in Barcelona, Sao Paolo, Mexico DF, Buenos Aires and San Francisco.

BaseKit is an online website builder and hosting service, which enables users to create next generation websites quickly and easily using an on-screen 'drag and drop' technique, eliminating the need to write code, and placing the website owner in full control of their own site. It allows those with little or no website development experience to create and maintain websites that contain the types of features that today's internet users have come to expect.

This latest round of funding follows the successful commercial launch of BaseKit less than ten months ago. The platform is being used by a wide range of businesses and individuals to create and manage their web presence. Since launching, the company has also attracted a strong community of web designers who have turned their backs on more fragmented and traditional website building tools such as WordPress, and are using BaseKit to create a website for third parties, because it is faster and easier than other alternatives.

Carles Ferrer, general partner with Nauta said: "We are delighted to be partnering with BaseKit as it fits perfectly in our portfolio from an industry vertical and market expansion perspective. We look forward to helping the company move to the next stage."

"BaseKit has an incredibly strong offering which has the potential to take advantage of a huge global market. It's a great example of the sort of technology-based innovation that the UK excels at. We are delighted to continue to support the business and look forward to helping it thrive," says Matthew Mead, managing director of investments at NESTA.

"It is clear that many small and medium sized businesses want a better platform to manage their online presence. Basekit is a truly WYSIWYG platform and users no longer need to be a web expert to deliver beautiful and functional websites" says Charles Grimsdale, partner at Eden Venture.

"There is a huge chasm of opportunity between simple web builders who produce appalling results, and complex CMS platforms that a real user would never be able to get to grips with. BaseKit is designed to fill that gap in the market - making it possible to create great looking, modern, functional websites, but with minimal complexity," adds Juan Lobato, CEO at BaseKit. "We are poised to take full advantage of that potential in the market, and will be using the additional funding from Nauta Capital, Eden Ventures and NESTA to accelerate our international roll-out."

About BaseKit
BaseKit disrupts the traditional web hosting market. BaseKit is an easy way to create, host and manage beautiful websites online. BaseKit is based on a flexible layout structure that allows users to create a website directly from a Photoshop design, or customize one of our 100+ professionally designed website templates. Users can build their website using the easy drag & drop interface, adding widgets for text or dynamic content like Twitter, RSS, Google Maps and more. This saves them thousands of pounds and help them to achieve beautiful and powerful results.

Basekit won Seedcamp 2008 and subsequently received investment from Eden Ventures and NESTA.

About Nauta Capital
Nauta Capital manages 3 VC funds and has offices in Barcelona and Boston. Nauta launched recently its third fund, Nauta III, and is expecting to announce its closing above EUR100M in Q211. Nauta has offices in Barcelona and Boston. Nauta invests between EUR0.5M and EUR7M mainly in 3 technology verticals: wireless; enterprise SW/Saas/Security, and ecommerce/internet. Nauta's target companies for investment are in their very early stage of development (Seed Capital) and until more advanced stages of development (Series A and B). Nauta actively invests in Western Europe and the US. www.nautacapital.com.

About NESTA
NESTA (the National Endowment for Science, Technology and the Arts), is an independent body with a mission to make the UK more innovative as a means of driving forward economic growth and solving some of the UK's major social challenges. NESTA Investments has the largest portfolios of early-stage businesses in the country and is a leading authority on how to grow new ideas.
www.nesta.org.uk

About Eden Ventures
Eden Ventures invests in technology companies in the telecommunications software, enterprise software, SaaS, digital media, e-commerce, Internet, social media and mobile sectors in Europe. As serial entrepreneurs, Eden's partners bring the highest levels of expertise in building early stage technology companies. In addition Eden brings a strong investment track record, offering potential for high returns in this exciting sector. Eden adds significant sales and marketing, organizational and financial focus and capabilities to the existing inherent technology value of its portfolio members. For more information, please visit www.edenventures.co.uk.

[Attachments] See images for this press release:
BaseKit Secures $6.5M for Global Expansion

ELSE PRESS RELEASES FROM THIS DATE:

New patient guidelines for heart devices

2011-04-18
DETROIT – A series of new guidelines for cardiac specialists has been developed to determine when heart failure patients should receive a mechanical heart-pumping device. "The new guidelines will likely affect who is referred for a mechanical circulatory support device, and how early in the process a physician would consider implanting a left ventricular assist device," says Jeffrey A. Morgan, M.D., associate director of Mechanical Circulatory Support at Henry Ford Hospital. "These guidelines have the ability to change clinical practice patterns for patients with advanced ...

Low-cost molecular medicine should be included in modern eye physicians' tool kit

2011-04-18
Dr. Richer, speaking at his 4th annual Nutrition & The Eye conference, April 16-17, hosted by the College of Optometry at the University of Missouri in St. Louis, says molecular medicine is beginning to provide hope for patients with declining sight when all other therapies have been exhausted. "These nutritional molecules have begun to be rigorously studied around the world in cardiology , cancer research and some human studies", Dr Richer reported. Dr. Richer has now accumulated a growing number of otherwise hopeless cases that retina specialists and other ophthalmologists ...

Sugarcane cools climate

2011-04-18
Palo Alto, CA—Brazilians are world leaders in using biofuels for gasoline. About a quarter of their automobile fuel consumption comes from sugarcane, which significantly reduces carbon dioxide emissions that otherwise would be emitted from using gasoline. Now scientists from the Carnegie Institution's Department of Global Ecology have found that sugarcane has a double benefit. Expansion of the crop in areas previously occupied by other Brazilian crops cools the local climate. It does so by reflecting sunlight back into space and by lowering the temperature of the surrounding ...

Arctic coasts on the retreat

2011-04-18
Bremerhaven/Geesthacht/Potsdam, 14 April 2011. The coastline in Arctic regions reacts to climate change with increased erosion and retreats by half a metre per year on average. This means substantial changes for Arctic ecosystems near the coast and the population living there. A consortium of more than thirty scientists from ten countries, including researchers from the Alfred Wegener Institute for Polar and Marine Research in the Helmholtz Association and from the Helmholtz Centre in Geesthacht, comes to this conclusion in two studies published in Estuaries and Coasts ...

Successful strategy developed to regenerate blood vessels

2011-04-18
VIDEO: Cardiologist Dr. Geoffrey Pickering of the University of Western Ontario describes a new strategy for stimulating the formation of highly functional new blood vessels in damaged tissue. Click here for more information. Researchers at The University of Western Ontario have discovered a strategy for stimulating the formation of highly functional new blood vessels in tissues that are starved of oxygen. Dr. Geoffrey Pickering and Matthew Frontini at the Schulich School of ...

Researchers get a first look at the mechanics of membrane proteins

Researchers get a first look at the mechanics of membrane proteins
2011-04-18
CHAMPAIGN, Ill. — In two new studies, researchers provide the first detailed view of the elaborate chemical and mechanical interactions that allow the ribosome – the cell's protein-building machinery – to insert a growing protein into the cellular membrane. The first study, in Nature Structural and Molecular Biology, gives an atom-by-atom snapshot of a pivotal stage in the insertion process: the moment just after the ribosome docks to a channel in the membrane and the newly forming protein winds its way into the membrane where it will reside. A collaboration between ...

Thorne Vet Launches ImmunoVET Serum Immunoglobulin Concentrate for Optimal Immune Support

2011-04-18
Thorne Vet, a division of Thorne Research, has introduced ImmunoVET for immune and gastrointestinal support. ImmunoVET is an immune globulin concentrate derived from purified bovine serum. It contains at least 45-percent immunoglobulin (IgG) - considerably more than the 20-25 percent typically seen in colostrums. ImmunoVET is purified from bovine serum, rather than bovine milk, hence there is no dairy component. ImmunoVET augments natural gut immunity by improving gut barrier function, activating gut immunity, and decreasing intestinal secretions for better stool consistency. ...

L-lysine may help schizophrenia sufferers cope

2011-04-18
Schizophrenia is a serious mental disorder that currently affects about one in every 200 people. Most patients find some relief from their symptoms by treatment with antipsychotics, however they may still suffer from cognitive and negative symptoms. These include poor concentration and memory, apathy, or a reduced ability to cope in social situations. Preliminary research published in BioMed Central's open access journal BMC Medicine shows that patients who received L-lysine alongside their normal medication found some reduction in the severity of their symptoms. In ...

Ancestors of land plants revealed

2011-04-18
It was previously thought that land plants evolved from stonewort-like algae. However, new research published in BioMed Central's open access journal BMC Evolutionary Biology shows that the closest relatives to land plants are actually conjugating green algae such as Spirogyra. Ancestors of green plants began to colonise the land about 500 million years ago and it is generally accepted that they evolved from streptophyte algae (a group of green, fresh water algae). But this group of algae is very diverse and currently ranges from simple, one cell, flagellates to more ...

Researchers inject nanofiber spheres carrying cells into wounds to grow tissue

2011-04-18
ANN ARBOR, Mich.---For the first time, scientists have made star-shaped, biodegradable polymers that can self-assemble into hollow, nanofiber spheres, and when the spheres are injected with cells into wounds, these spheres biodegrade, but the cells live on to form new tissue. Developing this nanofiber sphere as a cell carrier that simulates the natural growing environment of the cell is a very significant advance in tissue repair, says Peter Ma, professor at the University of Michigan School of Dentistry and lead author of a paper about the research scheduled for advanced ...

LAST 30 PRESS RELEASES:

Grant to support new research to address alcohol-related partner violence among sexual minorities

Biodiversity change amidst disappearing human traditions

New approaches to synthesize compounds for pharmaceutical research

Cohesion through resilient democratic communities

UC Santa Cruz chemists discover new process to make biodiesel production easier, less energy intensive

MD Anderson launches Institute for Cell Therapy Discovery & Innovation to deliver transformational new therapies

New quantum encoding methods slash circuit complexity in machine learning

New research promises an unprecedented look at how psychosocial stress affects military service members’ heart health

Faster measurement of response to antibiotic treatment in sepsis patients using Dimeric HNL

Cleveland Clinic announces updated findings in preventive breast cancer vaccine study

Intergenerational effects of adversity on mind-body health: Pathways through the gut-brain axis

Watch this elephant turn a hose into a sophisticated showering tool

Chimpanzees perform better on challenging computer tasks when they have an audience

New medical AI tool identifies more cases of long COVID from patient health records

Heat waves and adverse health events among dually eligible individuals 65 years and older

Catastrophic health expenditures for in-state and out-of-state abortion care

State divorce laws, reproductive care policies, and pregnancy-associated homicide rates

Emerging roles of high-mobility group box-1 in liver disease

Exploring the systematic anticancer mechanism in selected medicinal plants

University of Cincinnati researchers pen editorial analyzing present, future of emergency consent in stroke trials

Scarlet Macaw parents ‘play favorites,’ purposefully neglect younger chicks

One gene provides diagnoses for 30 patients whose condition was unexplained for years

Current practice and emerging endoscopic technology in the diagnosis of colorectal cancer

Decoding 17-beta-hydroxysteroid dehydrogenase 13: A multifaceted perspective on its role in hepatic steatosis and associated disorders

Key pathway leading to neurodegeneration in early stages of ALS identified

Ferroptosis in regulating treatment tolerance of digestive system tumors

A promising future in pancreatic incidentaloma detection

Stabilizing lithium-ion batteries: The vanadium touch

Innovative approaches to the surgical challenges in the management of gastroschisis

Mouse models for the study of liver fibrosis regression in vivo and ex vivo

[Press-News.org] BaseKit Secures $6.5M for Global Expansion
This latest round of funding follows the successful commercial launch of BaseKit less than ten months ago. The platform is being used by a wide range of businesses and individuals to create and manage their web presence.